Advanced Breast Cancer Therapies

This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive metastatic breast cancer. The papers cover various aspects including clinical trials, mechanisms of action, therapeutic resistance, combination strategies, and potential biomarkers.

Journals publishing in this area

1

Cancer Research

ISSN 0008-54727,072 articles in this topic

465h-index

0.54Impact

151.6KArticles

2.1MCitations

2

Journal of Clinical Oncology

Journal of Clinical Oncology

ISSN 0732-183X5,402 articles in this topic

733h-index

1.70Impact

166.4KArticles

4.4MCitations

3

Annals of Oncology

ISSN 0923-75342,531 articles in this topic

384h-index

1.10Impact

67.1KArticles

1.1MCitations

4

Clinical Cancer Research

ISSN 1078-04322,207 articles in this topic

417h-index

1.39Impact

27.3KArticles

1.6MCitations

5

European Journal of Cancer

ISSN 0959-80491,094 articles in this topic

295h-index

2.05Impact

41.9KArticles

833KCitations

6

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment

ISSN 0167-6806545 articles in this topic

219h-index

2.71Impact

12.4KArticles

504.1KCitations

7

CA A Cancer Journal for Clinicians

ISSN 0007-9235162 articles in this topic

266h-index

222.79Impact

4.9KArticles

894.1KCitations

8

International journal of oncology research.

ISSN 2664-665X3 articles in this topic

1h-index

52Articles

1Citations